Citations

Showing 10 of 108119 citations.

Efficacy of Ethanol Ablation in Long-Term Local Control of Neck Nodal Metastases in Adult Papillary Thyroid Carcinoma
Hay, Ian D. , Lee, Robert A, Charboneau, J William, Hay, Ian D , Lee, Robert A, Charboneau, J William

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 14, 2022 | Volume: 107 | Issue: 6 | Pages: e2636-e2637

10.1210/clinem/dgac018 | PMID 35030635 Get It

BATF promotes group 2 innate lymphoid cell–mediated lung tissue protection during acute respiratory virus infection
Wu, Xiaopeng , Kasmani, Moujtaba Y. , Zheng, Shikan , Khatun, Achia , Winkler, Wendy , Zander, Ryan , Burns, Robert , Taparowsky, Elizabeth J. , Sun, Jie , Winkler, Wendy , Zander, Ryan , Sun, Jie , Cui, Weiguo , Yao, Chen , Cui, Weiguo

Mayo Clinic

Science Immunology | January 14, 2022 | Volume: 7 | Issue: 67 | Pages: No page available

10.1126/sciimmunol.abc9934 | PMID 35030033 Get It

BATF regulates ILC2-mediated tissue repair and inflammation resolution during acute respiratory virus infection.
Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn’s Disease in the Era of Biologic Therapy
Aziz, Mohamed A. Abd El , Calini, Giacomo , Saeed, Hamadelneel, Stocchi, Luca , Merchea, Amit , Shawki, Sherief , Abd El Aziz, Mohamed A , Solafah, A , Calini, G , Colibaseanu, Dorin T, Colibaseanu, Dorin , Larson, David W.

Mayo Clinic

Journal of Crohn's and Colitis | January 14, 2022 | Volume: 16 | Issue: 7 | Pages: 1079-1088

10.1093/ecco-jcc/jjac012 | PMID 35045164 Get It

Abstract Background There is controversy regarding the postoperative outcomes in Crohn’s disease [CD] patients exposed to vedolizumab [VDZ] or ustekinumab [UST]. We aimed to describe our surgical outcomes in patients who underwent minimally invasive ileocolonic resection [MIS-ICR] for CD who had preoperative biologic therapy. Methods All consecutive adult patients who had MIS-ICR for CD between 2014 and 2021 at our institution were included. Patients were divided into four groups: VDZ, UST, anti-tumour necrosis factor [anti-TNF], and no biologic group. Timing between the last dose of biologics and surgery was per surgeon’s discretion. The primary outcome was intra-abdominal septic complications. Secondary outcomes included all 30-day complications. Results A total of 274 patients were identified. Of these, 113 [41.2%] patients had received anti-TNF, 52 [19%] had received UST, and 19 [7%] had received VDZ. There was no difference between the four groups regarding baseline risk factors. There was no difference between the four groups regarding intra-abdominal septic complications [4.4% for no biologic, 5.3% for anti-TNF, 5.8% for UST, and 5.3% for VDZ; p = 0.987], surgical site infection rate, overall 30-day morbidity, overall 30-day readmission, overall surgical and medical complications, urinary tract infection, pulmonary infections, or length of stay. Those results were consistent after a subgroup analysis based on complexity of the disease. Conclusions This retrospective analysis demonstrates an equivalent postoperative safety profile for patients treated with preoperative anti-TNF, VDZ, or UST versus no biologic therapy within 3 months of MIS-ICR for Crohn’s disease. Preoperative biologic therapy may not increase complications after minimally invasive ileocolonic resection in Crohn’s disease. Further studies with larger sample sizes are needed to confirm results.
Telemedicine for Preoperative Evaluation of Upper Eyelid Malposition: Reliability of Diagnosis and Surgical Plan
Wagner, Lilly H., Fairbanks, Aaron M., Hodge, David O., Bradley, Elizabeth A., Wagner, Lilly H. , Wagner, Lilly H., Fairbanks, Aaron M., Hodge, David O., Bradley, Elizabeth A.

Mayo Clinic

Ophthalmic Plastic & Reconstructive Surgery | January 14, 2022 | Volume: 38 | Issue: 4 | Pages: 364-368

10.1097/iop.0000000000002117 | PMID 35030149 Get It

Purpose: Outpatient visits and surgeries for nonurgent indications in ophthalmology have intermittently been restricted during the COVID-19 pandemic. Telemedicine services have rapidly gained acceptance during this period, and could improve patient access for routine oculoplastic evaluations in the future. The objective of this study is to investigate interobserver and intraobserver reliability of eyelid and brow position assessment and surgical plan when comparing photography-based and face-to-face evaluation. Methods: This was an observational study conducted at a single academic center. Thirty randomly selected patients who had completed an in-office evaluation for chief complaint of “drooping eyelids” between June 2019 and March 2020 were included. Virtual assessment of brow position, dermatochalasis, blepharoptosis, and margin-reflex distance 1 was performed by 2 oculoplastic surgeons based on external photographs, and a surgical plan was formulated. Fraction of agreement and Cohen’s κ were determined to evaluate reliability of the virtual assessment compared to face-to-face examination. Results: For 60 eyes from 30 study subjects, diagnostic reliability for observer A was near perfect for brow ptosis, substantial for blepharoptosis and moderate for dermatochalasis (κ = 0.86, 0.67, and 0.57, respectively); for observer B, reliability was moderate for brow and blepharoptosis and substantial for dermatochalasis (0.47, 0.59, and 0.79). Fraction of agreement for blepharoptosis was 94% in eyes where the eyelid margin was visible, and 66% in eyes where the eyelid margin was obscured by overhanging skin. Virtual margin-reflex distance 1 measurements were highly correlated with those obtained face to face (r = 0.77, p < 0.01). Fraction of agreement for surgical plan after virtual examination by observer A/B, respectively, was 100%/94% for brow lift, 90%/87% for blepharoptosis repair and 83%/83% for functional upper blepharoplasty. Conclusions: Virtual evaluation of upper eyelid and brow malposition can be performed with acceptable reliability. Co-existing dermatochalasis or brow ptosis may require special photographic technique or video examination to ensure an appropriate diagnosis. A photography-based preliminary surgical plan offers a viable alternative to face-to-face encounters.
Nitrous Oxide for Labor Analgesia at Altitude
Rollins, Mark D. , Firth, Paul G.

Mayo Clinic

Anesthesia & Analgesia | January 14, 2022 | Volume: 134 | Issue: 2 | Pages: 291-293

10.1213/ane.0000000000005751 | PMID 35030124 Get It

Book Review: Atlas of 360 Degree Skull Base Surgery
Rindler, Rima S.

Mayo Clinic

Operative Neurosurgery | January 14, 2022 | Volume: 22 | Issue: 3 | Pages: e138-e139

10.1227/ons.0000000000000072 Get It

The Alliance AMBUSH Trial: Rationale and Design
Mahajan, Anita , Peñas-Prado, Marta , Aldape, Kenneth, Hu, Leland , Basso, Michael R. , Nahed, Brian V. , Stott, Shannon L. , Geyer, Susan M. , Shih, Helen A. , Ligon, Keith L , Loughan, Ashlee R. , Leeper, Heather , Giannini, Caterina , Galanis, Evanthia

Mayo Clinic

Cancers | January 14, 2022 | Volume: 14 | Issue: 2 | Pages: 414

10.3390/cancers14020414 | PMID 35053576 Get It

Unlike medulloblastoma (MB) in children, robust prospective trials have not taken place for older patients due to the low incidence of MB in adults and adolescent and young adults (AYA). Current MB treatment paradigms for older patients have been extrapolated from the pediatric experience even though questions exist about the applicability of these approaches. Clinical and molecular classification of MB now provides better prognostication and is being incorporated in pediatric therapeutic trials. It has been established that genomic alterations leading to activation of the sonic hedgehog (SHH) pathway occur in approximately 60% of MB in patients over the age of 16 years. Within this cohort, protein patched homolog (PTCH) and smoothened (SMO) mutations are commonly found. Among patients whose tumors harbor the SHH molecular signature, it is estimated that over 80% of patients could respond to SHH pathway inhibitors. Given the advances in the understanding of molecular subgroups and the lack of robust clinical data for adult/AYA MB, the Alliance for Clinical Trial in Oncology group developed the AMBUSH trial: Comprehensive Management of AYA and Adult Patients with Medulloblastoma or Pineal Embryonal Tumors with a Randomized Placebo Controlled Phase II Focusing on Sonic Hedgehog Pathway Inhibition in SHH Subgroup Patients (Adult & Adolescent MedulloBlastoma Using Sonic Hedgehog Trial). This trial will enroll patients 18 years of age or older with MB (any molecular subgroup and risk stratification) or pineal embryonal tumor. Patients will be assigned to one of three cohorts: (1) average risk non-SHH-MB, (2) average risk SHH-MB, and (3) high risk MB or pineal embryonal tumors. All patients will receive protocol-directed comprehensive treatment with radiation therapy and chemotherapy. Patients with SHH-MB in cohort 1 will be randomized to a smoothened inhibitor or placebo as maintenance therapy for one year.
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise
Lestuzzi, Chiara , Tartuferi, Lucia, Viel, E, Angelis, Giulia De , Lonardi, Sara , Innocente, R. , Herrmann, Joerg , Bidoli, Ettore , Lonardi, Sara , Bergamo, Francesca , Guglielmi, Alessandra , Sinagra, Gianfranco , Herrmann, Joerg , Stolfo, Davide , Paoli, Antonino De , Banzato, Alberto , Buonadonna, Angela , Berretta, Massimiliano , Bergamo, Francesca

Mayo Clinic

The Oncologist | January 14, 2022 | Volume: 27 | Issue: 2 | Pages: e158-e167

10.1093/oncolo/oyab035 | PMID 35641220 Get It

AbstractBackgroundPhysical activity may increase the risk of cardiotoxicity (myocardial ischemia, major arrhythmias) of 5-Fluorouracil, but this risk has never been investigated for its prodrug capecitabine.Patients and MethodsOne hundred and ninety-two consecutive patients undergoing capecitabine chemotherapy from December 1, 2010 through July 31, 2016 were prospectively evaluated. The baseline evaluation included electrocardiography (ECG) and echocardiography (2DE); a follow-up evaluation, including ECG and exercise stress testing (2DE in case of ECG abnormalities), was done after ≥10 days of treatment. Cardiotoxicity was suspected from ischemic ECG changes, new kinetic abnormalities at 2DE, Lown classification ≥2 ventricular arrhythmia, symptomatic arrhythmias, or positive stress test, and confirmed by a negative stress test after capecitabine washout.ResultsCardiotoxicity was diagnosed in 32 patients (16.7%): six at rest and 26 during exercise. All 32 patients had ECG abnormalities: ST-segment changes (24 patients), negative T-waves (2) and/or arrhythmias: ventricular arrhythmias (14 cases), supraventricular tachycardia (2), complete heart block (1). Eight patients had typical symptoms, 6 had atypical symptoms, 1 had syncope, 17 (53%) were asymptomatic. Cardiotoxicity was more common in patients with atypical symptoms during daily life (OR = 15.7) and in those on a therapeutic schedule of 5 days/week (OR = 9.44).ConclusionCapecitabine cardiotoxicity is frequent, and often elicited by physical effort. Oncologists, cardiologists, and general practitioners should be aware of this risk. Active cardiotoxicity surveillance with ECG (and echocardiogram and/or stress testing in suspected cases) during therapy is recommended.Clinical Trials registration numberCRO-2010-17.
Efficacy of Tranexamic Acid in Reducing Seroma and Hematoma Formation Following Reduction Mammaplasty
Weissler, Jason M., Antezana, Luis A. , Curiel, Daniel , Kerivan, Lauren, Alsayed, Ahmed , Banuelos, Joseph, Harless, Christin A., Sharaf, Basel , Vijayasekaran, Aparna , Martinez‐Jorge, Jorys, Tran, Nho V. , Nguyen, Minh-Doan T. , Antezana, Luis , Sharaf, Basel A, Martinez-Jorge, Jorys, Sharaf, Basel A , Kuruoglu, Doga

Mayo Clinic

Aesthetic Surgery Journal | January 14, 2022 | Volume: 42 | Issue: 6 | Pages: 616-625

10.1093/asj/sjab399 | PMID 35029651 Get It

Abstract Background Tranexamic acid (TXA) has gained increasing recognition as a valuable pharmacologic agent within plastic surgery. Objectives The aim of this study was to investigate the value and safety profile of both intravenous and topically administered TXA in the setting of bilateral reduction mammaplasty. Methods A retrospective review was performed to identify consecutive patients who underwent bilateral reduction mammaplasty for symptomatic macromastia (January 2016-July 2021). Pertinent preoperative, intraoperative, and postoperative details were collected/reviewed. Primary outcome measures included hematoma requiring surgical evacuation and clinically significant/symptomatic seroma formation mandating percutaneous aspiration. Patients taking anticoagulation/antiplatelet medication or those with a history of thromboembolic diseases were excluded. Patients who had received TXA were compared to a historical control group who did not receive TXA within the same consecutive cohort. Results A total of 385 consecutive patients (770 breasts) were included. TXA was used in 514 (66.8%) cases (topical, 318 [61.9%]; intravenous, 170 [33.1%]; intravenous and topical, 26 [5.1%]). Neither seroma nor hematoma were impacted/reduced with TXA (P &gt; 0.05). Increased age (hazards ratio, 1.06 per 1-year increase; 95% CI, 1.004-1.118) significantly increased the risk of hematoma (P = 0.032). The use of drains significantly decreased the risk of seroma (P &lt; 0.0001). Increased BMI increased the risk of seroma (hazards ratio, 1.16 per 1-kg/m2 increase; 95% CI, 1.06-1.26; P = 0.0013). The use of TXA did not impact drain duration. Conclusions This study, the largest to date on the use of IV and topical TXA, did not find any reduction in risk when using TXA in breast reduction surgery. Level of Evidence: 3
Knowledge‐based quality control of organ delineations in radiation therapy
Nourzadeh, Hamidreza , Hui, C , Sadeghzadehyazdi, Nasrin, Watkins, William T., Dutta, Sunil W. , Alonso, Clayton E., Ahmad, Mahmoud, Trifiletti, Daniel M. , Siebers, Jeffrey V.

Mayo Clinic

Medical Physics | January 14, 2022 | Volume: 49 | Issue: 3 | Pages: 1368-1381

10.1002/mp.15458 | PMID 35028948 Get It

AbstractPurposeTo reduce the likelihood of errors in organ delineations used for radiotherapy treatment planning, a knowledge‐based quality control (KBQC) system, which discriminates between valid and anomalous delineations is developed.Method and MaterialsThe KBQC is comprised of a group‐wise inference system and anomaly detection modules trained using historical priors from 296 locally advanced lung and prostate cancer patient computational tomographies (CTs). The inference system discriminates different organs based on shape, relational, and intensity features. For a given delineated image set, the inference system solves a combinatorial optimization problem that results in an organ group whose relational features follow those of the training set considering the posterior probabilities obtained from support vector machine (SVM), discriminant subspace ensemble (DSE), and artificial neural network (ANN) classifiers. These classifiers are trained on nonrelational features with a 10‐fold cross‐validation scheme. The anomaly detection module is a bank of ANN autoencoders, each corresponding with an organ, trained on nonrelational features. A heuristic rule detects anomalous organs that exceed predefined organ‐specific tolerances for the feature reconstruction error and the classifier's posterior probabilities. Independent data sets with anomalous delineations were used to test the overall performance of the KBQC system. The anomalous delineations were manually manipulated, computer‐generated, or propagated based on a transformation obtained by imperfect registrations. Both peer‐review–based scoring system and shape similarity coefficient (DSC) were used to label regions of interest (ROIs) as normal or anomalous in two independent test cohorts.ResultsThe accuracy of the classifiers was 99.8%, and the minimum per‐class F1‐scores were 0.99, 0.99, and 0.98 for SVM, DSE, and ANN, respectively. The group‐wise inference system reduced the miss‐classification likelihood for the test data set with anomalous delineations compared to each individual classifier and a fused classifier that used the average posterior probability of all classifiers. For 15 independent locally advanced lung patients, the system detected 79% of the anomalous ROIs. For 1320 auto‐segmented abdominopelvic organs, the anomaly detection system identified anomalous delineations, which also had low Dice similarity coefficient values with respect to manually delineated organs in the training data set.ConclusionThe KBQC system detected anomalous delineations with superior accuracy compared to classification methods that judge only based on posterior probabilities.